Published in J Infect Dis on January 15, 2010
Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev (2012) 2.18
Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. PLoS Pathog (2012) 1.44
High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia. Emerg Infect Dis (2011) 1.22
Mechanisms of vancomycin resistance in Staphylococcus aureus. J Clin Invest (2014) 1.15
High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. Int J Infect Dis (2012) 1.11
An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection. Clin Infect Dis (2011) 0.96
The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia. BMC Infect Dis (2011) 0.92
Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiol (2011) 0.92
Difference in agr dysfunction and reduced vancomycin susceptibility between MRSA bacteremia involving SCCmec types IV/IVa and I-III. PLoS One (2012) 0.90
Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremia. Antimicrob Agents Chemother (2012) 0.86
Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother (2016) 0.80
Clinical, microbiological, and genetic characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a teaching hospital. Microb Drug Resist (2014) 0.79
Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2014) 0.77
High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus. Emerg Infect Dis (2016) 0.76
Staphylococcus aureus bacteremic pneumonia. Eur J Clin Microbiol Infect Dis (2016) 0.76
Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study. PLoS One (2015) 0.76
The safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysis. BMC Res Notes (2016) 0.75
Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J Infect Dis (2009) 2.72
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother (2006) 2.69
Clinical spectrum of urinary tract infections due on nontyphoidal Salmonella species. Clin Infect Dis (1996) 2.33
Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother (2005) 2.17
Silent and prolonged Aspergillus DNAemia in oncohematological patients receiving antifungal prophylaxis: a new phenomenon with clinical implications. Bone Marrow Transplant (2010) 2.02
Corynebacterium group D2 as a cause of alkaline-encrusted cystitis: report of four cases and characterization of the organisms. J Clin Microbiol (1985) 2.01
Visceral leishmaniasis in immunocompromised hosts. Am J Med (1987) 1.99
Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis (2009) 1.83
OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak. Antimicrob Agents Chemother (2010) 1.67
Systematic screening and treatment of asymptomatic bacteriuria in renal transplant recipients. Kidney Int (2010) 1.57
Urinary tract infection caused by Corynebacterium group D2: report of 82 cases and review. Rev Infect Dis (1991) 1.56
Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection. Am J Transplant (2012) 1.51
New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J Clin Microbiol (2002) 1.50
Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients. Transplantation (2006) 1.49
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain. Antimicrob Agents Chemother (2009) 1.44
[Impact of a non-compulsory antibiotic control program (PACTA): cost reductions and decreases in some nosocomial infections]. Enferm Infecc Microbiol Clin (2005) 1.43
[Analysis of publications on infectious diseases. A comparative study of ten countries in the period 2000-2009]. Enferm Infecc Microbiol Clin (2011) 1.41
[Treatment of gram negative bacilli bacteremia with intramuscular ceftriaxone in home care]. Med Clin (Barc) (1992) 1.40
Reversible acute renal failure caused by the combined use of foscarnet and cyclosporin in organ transplanted patients. Nephrol Dial Transplant (1995) 1.39
Rapid detection of herpes simplex virus DNA in genital ulcers by real-time PCR using SYBR green I dye as the detection signal. J Clin Microbiol (2002) 1.39
National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J Antimicrob Chemother (2011) 1.38
Fascioliasis in developed countries: a review of classic and aberrant forms of the disease. Medicine (Baltimore) (1995) 1.36
Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii. Antimicrob Agents Chemother (2011) 1.32
Analysis of changes in recent tuberculosis transmission patterns after a sharp increase in immigration. J Clin Microbiol (2006) 1.29
Rapid diagnosis of Mycobacterium tuberculosis bacteremia by PCR. J Clin Microbiol (1996) 1.24
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect (2013) 1.23
High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia. Emerg Infect Dis (2011) 1.22
Nosocomial spread of a Staphylococcus hominis subsp. novobiosepticus strain causing sepsis in a neonatal intensive care unit. J Clin Microbiol (2005) 1.22
Mycobacterium fortuitum complex endocarditis-case report and literature review. Clin Microbiol Infect (2002) 1.19
Bacteriuria with a multiply resistant species of Corynebacterium (Corynebacterium group D2): an unnoticed cause of urinary tract infection. J Infect Dis (1987) 1.16
Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J Infect Dis (1996) 1.15
Skin colonization by Corynebacterium groups D2 and JK in hospitalized patients. J Clin Microbiol (1988) 1.13
Molecular characterization of resistance to mupirocin in methicillin-susceptible and -resistant isolates of Staphylococcus aureus from nasal samples. J Clin Microbiol (2004) 1.13
Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis (2005) 1.11
Multidrug-resistant Acinetobacter baumannii Harboring OXA-24 carbapenemase, Spain. Emerg Infect Dis (2011) 1.10
VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, Spain. Emerg Infect Dis (2012) 1.09
[Invasive fungal infections in liver transplant recipients: analysis of 21 cases]. Med Clin (Barc) (1998) 1.07
Influence of Age and HLA Alleles on the CMV-Specific Cell-Mediated Immunity Among CMV-Seropositive Kidney Transplant Candidates. Am J Transplant (2015) 1.06
Epidemiology and clonality of methicillin-resistant and methicillin-susceptible Staphylococcus aureus causing bacteremia in a tertiary-care hospital in Spain. Infect Control Hosp Epidemiol (2005) 1.06
Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature. Medicine (Baltimore) (2014) 1.04
Use of a serum (1-->3)-beta-D-glucan assay for diagnosis and follow-up of Pneumocystis jiroveci pneumonia. Clin Infect Dis (2008) 1.03
Mannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in trans. Antimicrob Agents Chemother (2003) 1.02
New route of importation of Mycobacterium tuberculosis Beijing genotype. Emerg Infect Dis (2006) 1.01
Cutaneous infection by Phomopsis longicolla in a renal transplant recipient from Guinea: first report of human infection by this fungus. Transpl Infect Dis (2010) 1.01
Immunosuppressive therapy and infection after kidney transplantation. Transpl Infect Dis (2010) 1.01
[Staphylococcus aureus nasal colonization in medical students: importance in nosocomial transmission]. Enferm Infecc Microbiol Clin (2013) 1.01
Q fever endocarditis on porcine bioprosthetic valves. Clinicopathologic features and microbiologic findings in three patients treated with doxycycline, cotrimoxazole, and valve replacement. Ann Intern Med (1988) 1.00
Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome. Nephrol Dial Transplant (2010) 0.99
Trends in snakebite envenomation therapy: scientific, technological and public health considerations. Curr Pharm Des (2007) 0.98
Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review. Clin Infect Dis (2010) 0.97
Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis (2001) 0.97
Nosocomial spread of linezolid-resistant Staphylococcus haemolyticus infections in an intensive care unit. Diagn Microbiol Infect Dis (2009) 0.96
Efficacy of DNA amplification in tissue biopsy samples to improve the detection of invasive fungal disease. Clin Microbiol Infect (2013) 0.95
Six cases in which mesenteric lymphadenitis due to non-typhi Salmonella caused an appendicitis-like syndrome. Clin Infect Dis (1995) 0.95
Polymerase chain reaction for the diagnosis of pleural tuberculosis in immunocompromised and immunocompetent patients. Clin Infect Dis (1998) 0.95
Misindentification of Mycobacterium kumamotonense as M. tuberculosis. Emerg Infect Dis (2010) 0.94
Clinical and molecular characteristics of infections with CO2-dependent small-colony variants of Staphylococcus aureus. J Clin Microbiol (2010) 0.94
Molecular characterization of resistance to mupirocin in methicillin-resistant Staphylococcus aureus isolates in a tertiary hospital in Spain. J Antimicrob Chemother (2009) 0.93
Erythromycin and the treatment of Coxiella burnetii pneumonia. J Antimicrob Chemother (1991) 0.93
Pneumonia after heart transplantation: a multi-institutional study. Spanish Transplantation Infection Study Group. Clin Infect Dis (1998) 0.92
Fever due to inflammation in acute aortic dissection: Description and proposals for diagnostic and therapeutic management. Rev Esp Cardiol (2010) 0.92
Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort. Transpl Infect Dis (2012) 0.91
Experimental pathology of local tissue damage induced by Bothrops asper snake venom. Toxicon (2009) 0.91
Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS. Clin Infect Dis (1994) 0.90
Pseudomonas species Ve-2 septicemia. Eur J Clin Microbiol (1986) 0.90
Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group. Am J Transplant (2007) 0.90
Classifying extraintestinal non-typhoid Salmonella infections. QJM (1996) 0.90
[Osteoarticular infections by Salmonella non-typhi]. Enferm Infecc Microbiol Clin (1996) 0.89
Pulmonary zygomycosis in solid organ transplant recipients in the current era. Am J Transplant (2009) 0.89
Streptococcus bovis bacteraemia revisited: clinical and microbiological correlates in a contemporary series of 59 patients. J Infect (2010) 0.89
Urinary tract infection due to Corynebacterium urealyticum in kidney transplant recipients: an underdiagnosed etiology for obstructive uropathy and graft dysfunction-results of a prospective cohort study. Clin Infect Dis (2008) 0.89
Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain. J Clin Microbiol (2013) 0.89
Listeria monocytogenes meningitis in previously healthy adults: long-term follow-up. Q J Med (1993) 0.88
Reactivation of multisystemic sarcoidosis after immunosuppression withdrawal in a transplanted patient returning to chronic dialysis. Nephrol Dial Transplant (1998) 0.88
Detection of HIV-1 at between 20 and 49 copies per milliliter by the Cobas TaqMan HIV-1 v2.0 assay is associated with higher pretherapy viral load and less time on antiretroviral therapy. J Clin Microbiol (2010) 0.88
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. Enferm Infecc Microbiol Clin (2011) 0.88
Alkaline-encrusted pyelitis/cystitis and urinary tract infection due to corynebacterium urealyticum: a new severe complication after renal transplantation. Transplant Proc (1992) 0.87
Draft Genome Sequence of VIM-2-Producing Multidrug-Resistant Pseudomonas aeruginosa ST175, an Epidemic High-Risk Clone. Genome Announc (2013) 0.87
Influence of external factors in resistance of Corynebacterium urealyticum to antimicrobial agents. Antimicrob Agents Chemother (1996) 0.86
Bacteremia due to clonally derived methicillin-resistant, gentamicin-susceptible isolates and methicillin-susceptible, gentamicin-resistant isolates of Staphylococcus aureus. J Clin Microbiol (2007) 0.86
Lymphadenitis as a characteristic manifestation of disseminated tuberculosis in intravenous drug abusers infected with human immunodeficiency virus. J Infect (1987) 0.85
Visceral leishmaniasis (kala-azar) complicating acute leukaemia. J Infect (1983) 0.85
Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients. Transplantation (2009) 0.84
Community-associated Staphylococcus aureus infections in children. Expert Rev Anti Infect Ther (2010) 0.84
Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies. Antimicrob Agents Chemother (1993) 0.84
Inflammation induced by Bothrops asper venom. Toxicon (2009) 0.84
Multilocus sequence typing and further genetic characterization of the enigmatic pathogen, Staphylococcus hominis. PLoS One (2013) 0.84